Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Laryngoscope. 2012 Jul 2;122(8):1767–1772. doi: 10.1002/lary.23368

I.

Table Patient Demographics (N=21)

n %
Sex
    Male 18 85.71%
    Female 3 14.29%
Age at consent, yr
    Median 60.17
    Range 51.17 -87.42
T- Classification
    1/2 0 0%
    3 3 14.29%
    4 10 47.62%
    Recurrent at time of TL 5 23.81%
    Unknown or N/A* 3 14.29%
N- Classification
    N0 3 14.29%
    N+ 10 47.62%
    Recurrent at time of TL 5 23.81%
    Unknown or N/A* 3 14.29%
Surgical Procedure
    Total laryngectomy 15 71.43%
    Total laryngopharyngectomy 6 28.57%
Reconstruction
    None 15 71.43%
    ALT 5 23.81%
    Jejunum 1 4.76%
Radiation
    No 2 9.52%
    Preoperative treatment 6 28.57%
    Postoperative treatment 13 61.90%
Chemotherapy
    No 12 57.14%
    Yes 9 42.86%
Timing of TEP
    Primary 5 23.81%
    Secondary 16 76.19%
Recurrent disease during study period
    No 11 52.38%
    Yes 10 47.62%
Smoking at Diagnosis
    Never 2 9.52%
    Current 13 61.90%
    Former 6 28.57%
History of stricture
    No 16 76.19%
    Yes 5 23.81%
Reflux
    No 12 57.14%
    Yes 9 42.86%
*

Includes single case of Chondrosarcoma.

Includes two patients who received primary and secondary punctures; enlargement occurred after secondary tracheoesophageal puncture (TEP).

As noted by medication history.

TL = total laryngectomy; N/A = not available; ALT = anterolateralthigh.